AMSTERDAM — While hepatitis C virus-positive liver donation into HCV-positive recipients solves a number of public health problems, donation into HCV-negative recipients remains controversial, according to a presenter at the International Liver Congress.
Didier Samuel, MD, PhD, professor of hepatology and gastroenterology at Université Paris-Sud, Villejuif, said that the most convincing argument for using positive livers is the organ shortage. “Also, seroprevalence of HCV is higher in donors than in the overall population,” he said.
The U.S. is leading the way in HCV-positive graft usage, according to Samuel. “The rate was up to 15% in 2015,” he said. “Accordingly, we are seeing a decrease in the discarding of HCV-positive livers in the U.S.”